Literature DB >> 20226909

Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer--do we need both?

David Wiese1, Saad Sirop, Brian Yestrepsky, Maher Ghanem, Nader Bassily, Peter Ng, Weimin Liu, Ernesto Quiachon, Aamir Ahsan, Julio Badin, Sukamal Saha.   

Abstract

BACKGROUND: The aim of this study to analyze whether ultrastaging of initially negative nonsentinel lymph nodes (non-SLNs) would increase nodal positivity in colon cancer and rectal cancer.
METHODS: After SLN mapping (SLNM), SLNs were ultrastaged by 4 hematoxylin and eosin and 1 immunohistochemistry sections. A blinded pathologist reexamined initially negative non-SLNs by 3 additional hematoxylin and eosin and 1 immunohistochemistry sections.
RESULTS: In 156 colon cancer and 44 rectal cancer patients, 2,755 nodes were identified (494 SLNs and 2,261 non-SLNs). Metastases were detected in 20.9% of SLNs and 8.6% of non-SLNs (P<.0001). After ultrastaging non-SLNs, only .58% became positive for metastases in 12 patients. Of these, 10 already had positive lymph nodes, hence no change of staging occurred. Ultrastaging upstaged only 2 of 200 patients (1%).
CONCLUSIONS: The chance of finding additional metastases by ultrastaging of all non-SLNs is extremely low (<1%) and of little benefit. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20226909     DOI: 10.1016/j.amjsurg.2009.08.032

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

Review 1.  Management of nodal disease from colon cancer in the laparoscopic era.

Authors:  Corrado Pedrazzani; Lelde Lauka; Simone Sforza; Andrea Ruzzenente; Filippo Nifosì; GianGaetano Delaini; Alfredo Guglielmi
Journal:  Int J Colorectal Dis       Date:  2014-11-22       Impact factor: 2.571

2.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

3.  Ultrastaging of colon cancer by sentinel node biopsy using fluorescence navigation with indocyanine green.

Authors:  Christoph Hirche; Zarah Mohr; Sören Kneif; Sergiu Doniga; Dawid Murawa; Martin Strik; Michael Hünerbein
Journal:  Int J Colorectal Dis       Date:  2011-09-13       Impact factor: 2.571

Review 4.  Challenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapy.

Authors:  Sukamal Saha; Mohamed Elgamal; Meghan Cherry; Robin Buttar; Swetha Pentapati; Suresh Mukkamala; Kiran Devisetty; Sunil Kaushal; Mustafa Alnounou; Trevor Singh; Sandeep Grewal; David Eilender; Madan Arora; David Wiese
Journal:  Clin Exp Metastasis       Date:  2018-08-16       Impact factor: 5.150

Review 5.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 6.  The role of sentinel lymph node mapping in colon cancer: detection of micro-metastasis, effect on survival, and driver of a paradigm shift in extent of colon resection.

Authors:  Sukamal Saha; Bekele Philimon; Malore Efeson; Abebe Helina; Mohamed Elgamal; Gurmessa Kiya; Suga Hilkiah; Madan Arora; David Wiese; Yoko Kitagawa
Journal:  Clin Exp Metastasis       Date:  2021-10-26       Impact factor: 5.150

7.  Ex vivo localization and immunohistochemical detection of sentinel lymph node micrometastasis in patients with colorectal cancer can upgrade tumor staging.

Authors:  Fu-Long Wang; Fang Shen; De-Sen Wan; Zhen-Hai Lu; Li-Ren Li; Gong Chen; Xiao-Jun Wu; Pei-Rong Ding; Ling-Heng Kong; Zhi-Zhong Pan
Journal:  Diagn Pathol       Date:  2012-06-22       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.